Drug profile · INN
diazepam
ANTENEX 2
diazepam (ANTENEX 2) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Orion Laboratories Pty.. Route of administration: buccal. Current US regulatory status: approved.
Drug details — diazepam
- US status
- approved
- Class
- —
- Route
- BUCCAL
- Patents
- 5
- Programs
- 4
- Data quality
- 0.89
Quick answer
diazepam (ANTENEX 2) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Orion Laboratories Pty.. Route of administration: buccal. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is diazepam?
diazepam (ANTENEX 2) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Orion Laboratories Pty.. Route of administration: buccal. Current US regulatory status: approved.
What is the brand name for diazepam?
ANTENEX 2 is a marketed brand name for diazepam. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diazepam?
diazepam has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.